← FDA Drug Approvals (Drugs@FDA)
MESALAMINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-05-06
Drug application
- FDA Application #
ANDA209970- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MESALAMINE
- Generic name
- Mesalamine
- Active ingredients
- MESALAMINE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA
- First approval
- 2022-05-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown